Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Voluntarily Withdraws Daytrana Patches After Enhancing Adhesive

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm’s decision comes after patients and caregivers experienced difficulty removing the release liner from some Daytrana patches.
Advertisement

Related Content

Daytrana Manufacturing Woes Continue With FDA Warning Letter
Daytrana Manufacturing Woes Continue With FDA Warning Letter
A Sticky Situation For Shire’s Daytrana Patch, ISMP Reports
A Sticky Situation For Shire’s Daytrana Patch, ISMP Reports
Shire/Noven Daytrana Patch To Carry Similar Warnings To Other ADHD Drugs, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS066681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel